WVEWave Life Sciences Ltd.
$3.18-60% 1Y
$3.18
$3.0752 weeks$21.31
Is the business good?
Good
1 good, 3 without dataMargins widening. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margin direction, 3 years+1585.7 ptsderived
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is WVE?
- Share count, year on year
- +24%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | −764% |
| FY2021 | −310% |
| FY2022 | −4459% |
| FY2023 | −60% |
| FY2024 | −102% |
| FY2025 | −504% |
Details›
- Free cash flow, trailing twelve months
- −$193M
- Net income, trailing twelve months
- −$202M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.